These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2101169)

  • 1. Immunological pattern in heterozygote beta thalassemic subjects.
    Gallerani M; Cicognani I; Ricci A; Martinelli L; Dall'Ara G; Ferrari R; Faggioli M
    Riv Eur Sci Med Farmacol; 1990 Jun; 12(3):191-5. PubMed ID: 2101169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of folate and vitamin B12 in beta thalassemia minor.
    Gallerani M; Cicognani I; Ballardini P; Martinelli L; Ricci A; Dall'Ara G; Faggioli M
    Riv Eur Sci Med Farmacol; 1990; 12(4-5):247-50. PubMed ID: 2103964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epo serum levels in heterozygous beta-thalassemia.
    Vedovato M; Salvatorelli G; Taddei Masieri M; Vullo C
    Haematologia (Budap); 1993; 25(1):19-24. PubMed ID: 8339995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rheological behaviour of red blood cells in beta and deltabeta thalassemia trait.
    Vayá A; Iborra J; Falcó C; Moreno I; Bolufer P; Ferrando F; Pérez ML; Justo Aznar
    Clin Hemorheol Microcirc; 2003; 28(2):71-8. PubMed ID: 12652012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Average life expectancy of heterozygous beta thalassemic subjects.
    Gallerani M; Cicognani I; Ballardini P; Savelli S; Martinelli L; Ricci A; Coletti M; Faggioli M; Stabellini G
    Haematologica; 1990; 75(3):224-7. PubMed ID: 2227618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virological, immunological and histological aspects in adult beta-thalassemic patients with chronic hepatitis C virus infection.
    Siagris D; Giannakoulas N; Christofidou M; Tsamandas A; Lekkou A; Thomopoulos K; Zoumbos N; Labropoulou-Karatza Ch
    Liver Int; 2004 Jun; 24(3):204-9. PubMed ID: 15189270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiovascular diseases in heterozygote beta-thalassemia subjects].
    Gallerani M; Faggioli M; Martinelli L; Dall'Ara G
    Minerva Med; 1989 Apr; 80(4):367-9. PubMed ID: 2725938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Heterozygote beta-thalassemia and neoplastic pathology].
    Gallerani M; Pulga A; Martinelli L; Ricci A; Bottini E; Dall'Ara G; Faggioli M
    Minerva Med; 1990 Mar; 81(3):175-80. PubMed ID: 2320284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biophysical characterization of beta-thalassemic red blood cells.
    Desouky OS; Selim NS; El-Bakrawy EM; El-Marakby SM
    Cell Biochem Biophys; 2009; 55(1):45-53. PubMed ID: 19585085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological distances in dermatoglyphics of beta-thalassemic subjects.
    Gualdi Russo E
    Acta Anthropogenet; 1984; 8(3-4):223-30. PubMed ID: 6545754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythrocyte zincprotoporphyrin (ZPP) in subjects with heterozygote beta-thalassemia, acquired non-microcytic anemias and iron deficiency.
    Cocuzza S; Avola G
    Boll Soc Ital Biol Sper; 1984 Nov; 60(11):2171-8. PubMed ID: 6525276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocyte subsets and specific T-cell immune response in thalassemia.
    Pattanapanyasat K; Thepthai C; Lamchiagdhase P; Lerdwana S; Tachavanich K; Thanomsuk P; Wanachiwanawin W; Fucharoen S; Darden JM
    Cytometry; 2000 Feb; 42(1):11-7. PubMed ID: 10679738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of hepatitis C virus antibodies in thalassemic patients in the south of Thailand.
    Laosombat V; Pornpatkul M; Wongchanchailert M; Worachat K; Wiriyasatienku A
    Southeast Asian J Trop Med Public Health; 1997 Mar; 28(1):149-53. PubMed ID: 9322298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pattern of thalassemia in Naples.
    Pepe G; Lupi L; Mastrobuono A; Carestia C; Lania A; Luzzatto L
    Birth Defects Orig Artic Ser; 1982; 18(7):177-84. PubMed ID: 7159727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Globin chain synthesis is a useful complementary tool in the differential diagnosis of thalassemias.
    Khatami S; Dehboneh SR; Sadeghi S; Mirzazadeh R; Saeedi P; Bayat P; Najmabadi H; Zeinali S; Akbari MT; Ardjmand M; Amirkhani A
    Hemoglobin; 2007; 31(3):333-41. PubMed ID: 17654070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of a new osmotic test in the screening of heterozygous beta thalassemias.
    Anichini P; Reynaudo G; Pacini G
    Scand J Clin Lab Invest; 1983 Apr; 43(2):171-3. PubMed ID: 6612224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The heterozygote beta-thalassemic patient with regard to radiological hazards].
    Toti A; Nibbio A; Camerini G; Buriani C; Bariani L; Zerbinati C; Cervi PM; Castaldi G
    Radiol Med; 1984; 70(7-8):516-9. PubMed ID: 6535170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of hepatitis B vaccine in multi-transfused thalassemic patients with and without hepatitis C infection: a comparative study with healthy controls.
    Froutan-Pishbijari H; Ghofrani H; Mirmomenm S; Kazemi-Asl S; Nassiri-Toosi M; Farahvash MJ; Toroghi HH; Aminian K; Mansour-Ghanaei F; Bagherzadeh AH
    Med Sci Monit; 2004 Dec; 10(12):CR679-83. PubMed ID: 15567986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impairment of natural killer (NK) function in carriers and patients with thalassemia major.
    Goicoa MA; Estevez ME; Ballart IJ; Diez RA; Peñalver JA; de Miani SA; Sen L
    Nouv Rev Fr Hematol (1978); 1986; 28(2):75-9. PubMed ID: 3737398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effects of occupational exposure to nitrogen dioxide (NO2) on the immunological parameters in workers].
    Rutowski J; Moszczyński P; Dobrowolski JW; Bem S; Krochmal D
    Med Pr; 1998; 49(4):341-51. PubMed ID: 9816580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.